Amyloidosis : A Clinical Overview - 17/04/13
Résumé |
Amyloidosis is the name for protein-folding diseases characterized by extracellular deposition of a specific soluble precursor protein that aggregates in the form of insoluble fibrils. The classification of amyloidosis is based on the chemical characterization of the precursor protein. Deposition of amyloid is localized or systemic. The 4 main types of systemic amyloidosis are AL, AA, ATTR, and Aβ 2M type. A schematic approach is proposed for the clinical management of systemic amyloidosis. The importance of typing amyloid with confidence, the usefulness of imaging techniques, the principles of treatment, and the need for well-planned treatment monitoring during follow-up are discussed.
Le texte complet de cet article est disponible en PDF.Keywords : Systemic amyloidosis, Amyloid fibril, Protein misfolding, Precursor protein, Typing, Diagnosis, Treatment, Disease monitoring
Plan
| Funding Sources: None. |
|
| Conflict of Interest: Previous member of the Clinical Advisory Board of Neurochem; Chair of an External Safety Advisory Committee of GSK. |
Vol 39 - N° 2
P. 323-345 - mai 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?

